Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Clinical trial NCT05833867 · RECRUITING

Trial details

NCT number: NCT05833867
Sponsor: Shilpa Gupta, MD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Localized Muscle Invasive Bladder Urothelial Carcinoma Muscle-Invasive Bladder Carcinoma

Start date: 2024-04-01
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.